Christelle Johnson

Company: Personalis Inc

Job title: Senior Field Applications Scientist

Seminars:

Ultra-Sensitive Tumor-Informed ctDNA Monitoring of Molecular Residual Disease (MRD) & Response to Immunotherapy in the Advanced Disease Setting 2:10 pm

Ultra-sensitive ctDNA assays are required for accurate classification of patient MRD status and treatment monitoring Low ctDNA levels are commonly observed, even in late stage disease, with positive ctDNA detections in these studies occurring as low as 2.3 PPM Detections down to low PPM levels correlate strongly with RECIST-derived classifications of responseRead more

day: Day 2 Track A PM